Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Frontiers in Pharmacology|October 3, 2022
Current landscape of personalized clinical treatments for triple-negative breast cancerJun Zhang, Yu Xia, Xiaomei Zhou, et al.
Nature Methods|February 27, 2019
One-step generation of modular CAR-T cells with AAV-Cpf1Xiaoyun Dai, Jonathan J Park, Yaying Du, et al.
Molecular Carcinogenesis|June 11, 2024
HDAC inhibitor regulates the tumor immune microenvironment via pyroptosis in triple negative breast cancerXue Yang, Xiaoqing Cui, Ge Wang, et al.
Frontiers in Oncology|June 27, 2022
Cyclin-Dependent Kinase Inhibitors Function as Potential Immune Regulators <i>via</i> Inducing Pyroptosis in Triple Negative Breast CancerTao Xu, Zhen Wang, Jiahao Liu, et al.
Frontiers in Endocrinology|July 19, 2023
Mutational profiling of Chinese patients with thyroid cancerYaying Du, Shu Zhang, Gang Zhang, et al.
Biomaterials Research|May 11, 2026
Genetically Engineered Cell Membrane-Coated Nanodrug for Targeted Treatment of Thyroid CancerShaojie Xu, Xingyin Li, Youyun Peng, et al.
Frontiers in Nutrition|January 31, 2022
Nutritional Risk Index Predicts Survival in Patients With Breast Cancer Treated With Neoadjuvant ChemotherapyLi Chen, Yihang Qi, Xiangyi Kong, et al.
Frontiers in Oncology|January 11, 2020
SIX1 Activates STAT3 Signaling to Promote the Proliferation of Thyroid Carcinoma via EYA1Deguang Kong, Anping Li, Yu Liu, et al.
Life Sciences|September 26, 2022
Regulation of antitumor miR-205 targets oncogenes: Direct regulation of lymphoid specific helicase and its clinical significanceXiaoqing Cui, Xue Yang, Ge Wang, et al.
Oncogene|June 29, 2026
DNA methylation-mediated silencing of STAT5A drives breast cancer metastasis via dual regulation of EMT and immunosuppressive microenvironmentXue Yang, Yuhang Su, Yushi Ying, et al.
Pageof 4